Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.
- DOI
- 10.1192/bjp.2023.79
- Published
- 2023 Dec
- Container
- The British journal of psychiatry : the journal of mental science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1192/bjp.2023.79,
title = {Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.},
author = {Loo C and Glozier N and Barton D and Baune BT and Mills NT and Fitzgerald P and Glue P and Sarma S and Galvez-Ortiz V and Hadzi-Pavlovic D and Alonzo A and Dong V and Martin D and Nikolin S and Mitchell PB and Berk M and Carter G and Hackett M and Leyden J and Hood S and Somogyi AA and Lapidus K and Stratton E and Gainsford K and Garg D and Thornton NLR and Fourrier C and Richardson K and Rozakis D and Scaria A and Mihalopoulos C and Chatterton ML and McDonald WM and Boyce P and Holtzheimer PE and Kozel FA and Riva-Posse P and Rodgers A},
year = {2023},
journal = {The British journal of psychiatry : the journal of mental science},
doi = {10.1192/bjp.2023.79},
url = {https://doi.org/10.1192/bjp.2023.79}
}RIS
TY - JOUR TI - Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. AU - Loo C AU - Glozier N AU - Barton D AU - Baune BT AU - Mills NT AU - Fitzgerald P AU - Glue P AU - Sarma S AU - Galvez-Ortiz V AU - Hadzi-Pavlovic D AU - Alonzo A AU - Dong V AU - Martin D AU - Nikolin S AU - Mitchell PB AU - Berk M AU - Carter G AU - Hackett M AU - Leyden J AU - Hood S AU - Somogyi AA AU - Lapidus K AU - Stratton E AU - Gainsford K AU - Garg D AU - Thornton NLR AU - Fourrier C AU - Richardson K AU - Rozakis D AU - Scaria A AU - Mihalopoulos C AU - Chatterton ML AU - McDonald WM AU - Boyce P AU - Holtzheimer PE AU - Kozel FA AU - Riva-Posse P AU - Rodgers A PY - 2023 JO - The British journal of psychiatry : the journal of mental science DO - 10.1192/bjp.2023.79 UR - https://doi.org/10.1192/bjp.2023.79 ER -
APA
C, L., N, G., D, B., BT, B., NT, M., P, F., P, G., S, S., V, G., D, H., A, A., V, D., D, M., S, N., PB, M., M, B., G, C., M, H., J, L., S, H., AA, S., K, L., E, S., K, G., D, G., NLR, T., C, F., K, R., D, R., A, S., C, M., ML, C., WM, M., P, B., PE, H., FA, K., P, R., & A, R. (2023). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.. The British journal of psychiatry : the journal of mental science. https://doi.org/10.1192/bjp.2023.79
Source records
- pubmed · retrieved 2026-09-26T14:03:31.954Z